uroweb.org/wp-content/uploa...
Reading for those making a decision.
Benefits and Risks of Primary Treatme... - Advanced Prostate...
Benefits and Risks of Primary Treatments for High-risk Localized PCa : InternationalMultidisciplinary Systematic Review
Written by
maley2711
To view profiles and participate in discussions please or .
2 Replies
•
Nice read, thanks for posting... as it says, we will know a lot more when the results of SPCG-15, a randomized trial of 1200 comparing RT vs RP for stage 3 N0M0, are available. I chose the RT/ADT route for t3bN1+SV.
Not what you're looking for?
You may also like...
Correct Therapy for High Risk PCa (Gleason 9)
I am diagnosed with a HighRisk PCa (GL 4 + 5 = 9, PSA 12,5, Staging Ta2 - Ta3 after Biopsy, CT and...
Zytiga for high-risk non-metastatic PCa?
Hi fellows, My cancer was diagnosed as Gleason 9 and non-metastatic. It's been treated in recent...
Vitamin D Supplementation in PCa: A Systematic Review of Randomized Control Trials.
New meta-analyis below [1].
"Current evidence suggests that vitamin D supplementation in...
Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. significant association between vasectomy and any-grade PCa
https://www.sciencedirect.com/science/article/pii/S2666168322005870?ref=cra_js_challenge&fr=RR-1...
Circulating Tumor Cells in Men Who Have Undergone Prostatectomy for Clinically Localized, High-Risk PCa.
New U.S. study below [1].
It used to be that a prostatectomy [RP] would be halted if the cancer was...
Related Posts
- The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis
- Evaluation of Cancer-Specific Mortality with Surgery Versus RT as Primary Therapy for Localized High-Grade PCa in younger Men
- Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized PCa.
- Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive PCa.
Treatment of High Risk Advanced and M1 Disease: Is There a Role for Treatment of the Primary?
